Drug
Ro7198457
Ro7198457: highest development phase Phase 2, developed by BioNTech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- BioNTech
Trials
| Drug | Phase | Indication |
|---|---|---|
| RO7198457 intravenous (IV) NCT04486378 | Phase 2 | Colorectal Cancer Stage II |
Latest
No recent events.
Follow Ro7198457 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.